Whitehawk Therapeutics (WHWK) Operating Leases: 2019-2024
Historic Operating Leases for Whitehawk Therapeutics (WHWK) over the last 4 years, with Dec 2024 value amounting to $565,000.
- Whitehawk Therapeutics' Operating Leases fell 55.41% to $565,000 in Q4 2024 from the same period last year, while for Dec 2024 it was $565,000, marking a year-over-year decrease of 55.41%. This contributed to the annual value of $565,000 for FY2024, which is 55.41% down from last year.
- As of Q4 2024, Whitehawk Therapeutics' Operating Leases stood at $565,000, which was down 40.27% from $946,000 recorded in Q3 2024.
- Whitehawk Therapeutics' 5-year Operating Leases high stood at $1.8 million for Q2 2022, and its period low was $9,955 during Q2 2020.
- In the last 3 years, Whitehawk Therapeutics' Operating Leases had a median value of $1.3 million in 2023 and averaged $1.2 million.
- As far as peak fluctuations go, Whitehawk Therapeutics' Operating Leases slumped by 96.54% in 2020, and later surged by 269.81% in 2023.
- Over the past 5 years, Whitehawk Therapeutics' Operating Leases (Quarterly) stood at $9,955 in 2020, then reached $605,000 in 2021, then soared by 174.55% to $1.7 million in 2022, then dropped by 23.72% to $1.3 million in 2023, then crashed by 55.41% to $565,000 in 2024.
- Its Operating Leases stands at $565,000 for Q4 2024, versus $946,000 for Q3 2024 and $1.1 million for Q2 2024.